Skip to main content

Ludwig Enterprises, Inc.

corporate_fare Company Profile

Ludwig Enterprises, Inc.

LUDG·OTC·Industrial Applications And Services·CIK 0001960262

Ludwig Enterprises, Inc. is an early-stage genomic technology company that develops screening tests for inflammation-related chronic diseases, including cancers. Originally incorporated in 1988 and reorganized as a Nevada corporation in 2006, Ludwig pivoted in late 2021 to focus on genomic diagnostics, specifically mRNA-based testing. The company began actively pursuing its oncology diagnostics strategy in early 2022. Ludwig's technology utilizes a novel mRNA-based approach focused on dynamic gene expression, building on advances from the Human Genome Project. The company's first product candidate is the Revealia™ Breast test, which is anticipated to trial-launch in the second quarter of 2026. This platform integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits. Ludwig believes it is the first to employ a non-invasive cheek swab to collect sufficient mRNA samples for analysis. The approach aims to enable earlier detection of inflammation-driven disease and support personalized treatment decisions. The business model combines a business-to-business-to-consumer (B2B2C) strategy with partnerships through CLIA-certified laboratories. Ludwig intends to offer home collection kits directly to patients, supported by certified genetic counselors, and enable independent laboratories to provide the Revealia™ Breast test as a Laboratory Developed Test (LDT). The company relies on proprietary methods and intellectual property.

Ludwig Enterprises, Inc. (OTC:LUDG) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 10 items for LUDG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 8/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for LUDG spans 8-K, SCHEDULE 13D, 10-Q, 4.

Recent high-impact activity:

  • FOXO Gains 57.7% Voting Control of Ludwig Via Preferred-Share Proxies
  • FOXO to Buy 71% of Ludwig Preferred, Securing 57.7% Voting Control
  • Auditor Stephano Slack Resigns; No Successor Engaged
  • Ludwig Reports Negative Q1 Revenue, Non-Cash Net Income Amid Going Concern
  • Quarterly Report Reveals Ongoing Going Concern, Ineffective Controls, and Massive Dilution Despite Non-Cash Net Income

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$2.24M
Diluted EPS
-$0.01
Op. Cash Flow
-$644.84K
Operating Income
-$1.77M
Cash & Equivalents
$0
Debt / Equity
0.00×
Shares Outstanding
162.57M sh
Source: 10-K · filed 2026-03-16 · accession 0001213900-26-028315
Browse all tickers starting with L →
$0.0035
52-week range · as of 2026-11-02 $0.0027 – $0.20
Market cap
$585.08K
Volume
8.7K (0.4× avg)
3-mo avg 23.3K
Last traded · 2026-10-29

show_chartPrice Chart

Loading chart...

feed LUDG - Latest Insights

LUDG
Nov 02, 2026, 4:18 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0035
Real-time Price: $0.0035 info
Change: $0 (0%) info
Market Cap: $585.085K info
LUDG
Oct 29, 2026, 8:28 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $0.0035
Real-time Price: $0.0035 info
Change: $0 (0%) info
Market Cap: $585.085K info
LUDG
Oct 06, 2026, 12:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0034
Real-time Price: $0.0035 info
Change: +$0.0001 (+3%) info
Market Cap: $585.085K info
LUDG
May 29, 2026, 1:31 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.0275
Real-time Price: $0.0035 info
Change: -$0.024 (-87%) info
Market Cap: $585.085K info
LUDG
May 29, 2026, 1:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0275
Real-time Price: $0.0035 info
Change: -$0.024 (-87%) info
Market Cap: $585.085K info
LUDG
May 01, 2026, 11:21 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.035
Real-time Price: $0.0035 info
Change: -$0.0315 (-90%) info
Market Cap: $585.085K info
LUDG
Apr 02, 2026, 2:09 PM EDT
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.035
Real-time Price: $0.0035 info
Change: -$0.0315 (-90%) info
Market Cap: $585.085K info
LUDG
Mar 16, 2026, 4:20 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.039
Real-time Price: $0.0035 info
Change: -$0.0355 (-91%) info
Market Cap: $585.085K info
LUDG
Feb 11, 2026, 9:54 PM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.022
Real-time Price: $0.0035 info
Change: -$0.0185 (-84%) info
Market Cap: $585.085K info
LUDG
Feb 11, 2026, 11:56 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.022
Real-time Price: $0.0035 info
Change: -$0.0185 (-84%) info
Market Cap: $585.085K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets